SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth

Published:2017-02 Issue:2 Volume:483 Page:880-884
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Luo Jie,Bao Yu-chen,Ji Xian-xiu,Chen Bin,Deng Qin-fang,Zhou Song-wen

Funder

National Natural Science Foundation of China

Shanghai Science and Technology Commission

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference19 articles.

1. Mammalian sirtuins: biological insights and disease relevance;Haigis;Annu. Rev. Pathol.,2010

2. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase;Imai;Nature,2000

3. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases;Imai;Trends Pharmacol. Sci.,2010

4. SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3beta/beta-catenin signaling;Chen;Hepatology,2013

5. The histone deacetylase SIRT2 stabilizes Myc oncoproteins;Liu;Cell Death Differ.,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of sirtuins in non‑small cell lung cancer (Review);Oncology Reports;2024-07-30

2. Selective inhibition of SIRT2: A disputable therapeutic approach in cancer therapy;Bioorganic Chemistry;2024-02

3. Construction of a prediction model for postoperative prognosis in patients with resectable cholangiocarcinoma based on SIRT2 expression;Journal of Zhejiang University (Medical Sciences);2023-12-01

4. Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy;Acta Pharmaceutica Sinica B;2023-11

5. The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment;Pharmacology & Therapeutics;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3